;PMID: 11890673
;source_file_2914.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..117] = [t:59..117]
;2)section:[e:121..191] = [t:121..191]
;3)section:[e:195..324] = [t:195..324]
;4)sentence:[e:328..502] = [t:328..502]
;5)sentence:[e:503..607] = [t:503..607]
;6)sentence:[e:608..791] = [t:608..791]
;7)sentence:[e:792..881] = [t:792..881]
;8)sentence:[e:882..1213] = [t:882..1213]
;9)sentence:[e:1214..1384] = [t:1214..1384]
;10)section:[e:1385..1416] = [t:1385..1416]
;11)section:[e:1420..1465] = [t:1420..1465]

;section 0 Span:0..53
;Biochem Biophys Res Commun.  2002 Mar 22;292(1):71-8.
(SEC
  (FRAG (NNP:[0..7] Biochem) (NNP:[8..15] Biophys) (NNP:[16..19] Res)
        (NNP:[20..26] Commun) (.:[26..27] .) (CD:[29..33] 2002)
        (NNP:[34..37] Mar) (CD:[38..40] 22) (CD:[40..44] ;292)
        (-LRB-:[44..45] -LRB-) (CD:[45..46] 1) (-RRB-:[46..47] -RRB-)
        (::[47..48] :) (CD:[48..50] 71) (::[50..51] -) (CD:[51..53] 8.)))

;sentence 1 Span:59..117
;Sp1 and Sp3 activate the rat connexin40 proximal promoter.
;[59..62]:gene-protein:"Sp1"
;[67..70]:gene-protein:"Sp3"
;[88..98]:gene-protein:"connexin40"
(SENT
  (S-HLN
    (NP-SBJ (NN:[59..62] Sp1) (CC:[63..66] and) (NN:[67..70] Sp3))
    (VP (VBP:[71..79] activate)
      (NP (DT:[80..83] the) (NN:[84..87] rat) (NN:[88..98] connexin40)
          (JJ:[99..107] proximal) (NN:[108..116] promoter)))
    (.:[116..117] .)))

;section 2 Span:121..191
;Teunissen BE, van Amersfoorth SC, Opthof T, Jongsma HJ, Bierhuizen MF.
(SEC
  (FRAG (NNP:[121..130] Teunissen) (NNP:[131..133] BE) (,:[133..134] ,)
        (NNP:[135..138] van) (NNP:[139..150] Amersfoorth) (NNP:[151..153] SC)
        (,:[153..154] ,) (NNP:[155..161] Opthof) (NNP:[162..163] T)
        (,:[163..164] ,) (NNP:[165..172] Jongsma) (NNP:[173..175] HJ)
        (,:[175..176] ,) (NNP:[177..187] Bierhuizen) (NNP:[188..191] MF.)))

;section 3 Span:195..324
;Department of Medical Physiology, University Medical Center Utrecht, 3508 AB 
;Utrecht, The Netherlands. B.E.J.Teunissen@med.uu.nl
(SEC
  (FRAG (NNP:[195..205] Department) (IN:[206..208] of) (NNP:[209..216] Medical)
        (NNP:[217..227] Physiology) (,:[227..228] ,) (NNP:[229..239] University)
        (NNP:[240..247] Medical) (NNP:[248..254] Center)
        (NNP:[255..262] Utrecht) (,:[262..263] ,) (CD:[264..268] 3508)
        (NN:[269..271] AB) (NNP:[273..280] Utrecht) (,:[280..281] ,)
        (DT:[282..285] The) (NNP:[286..297] Netherlands) (.:[297..298] .)
        (NNP:[299..318] B.E.J.Teunissen@med) (.:[318..324] .uu.nl)))

;sentence 4 Span:328..502
;The rat gap junction protein connexin40 (rCx40) has a characteristic 
;developmental and regional expression pattern, for which the exact regulatory
; mechanisms are not known.
;[357..367]:gene-protein:"connexin40"
;[369..374]:gene-protein:"rCx40"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[328..331] The) (NN:[332..335] rat)
        (NML
          (NML (NN:[336..339] gap) (NN:[340..348] junction))
          (NN:[349..356] protein))
        (NN:[357..367] connexin40))
      (NP (-LRB-:[368..369] -LRB-) (NN:[369..374] rCx40)
          (-RRB-:[374..375] -RRB-)))
    (VP (VBZ:[376..379] has)
      (NP (DT:[380..381] a) (JJ:[382..396] characteristic)
        (NML
          (NML (JJ:[398..411] developmental)
            (NML-2 (-NONE-:[411..411] *P*)))
          (CC:[412..415] and)
          (NML (JJ:[416..424] regional)
            (NML-2 (NN:[425..435] expression) (NN:[436..443] pattern)))))
      (,:[443..444] ,)
      (SBAR
        (WHPP-3 (IN:[445..448] for)
          (WHNP (WDT:[449..454] which)))
        (S
          (NP-SBJ-1 (DT:[455..458] the) (JJ:[459..464] exact)
                    (JJ:[465..475] regulatory) (NNS:[477..487] mechanisms))
          (VP (VBP:[488..491] are) (RB:[492..495] not)
            (VP (VBN:[496..501] known)
              (NP-1 (-NONE-:[501..501] *))
              (PP-3 (-NONE-:[501..501] *T*)))))))
    (.:[501..502] .)))

;sentence 5 Span:503..607
;To identify the molecular factors controlling Cx40  expression, its proximal
;promoter was characterized.
;[549..553]:gene-protein:"Cx40"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[503..503] *))
      (VP (TO:[503..505] To)
        (VP (VB:[506..514] identify)
          (NP
            (NP (DT:[515..518] the) (JJ:[519..528] molecular)
                (NNS:[529..536] factors))
            (VP (VBG:[537..548] controlling)
              (NP (NN:[549..553] Cx40) (NN:[555..565] expression)))))))
    (,:[565..566] ,)
    (NP-SBJ-1 (PRP$:[567..570] its) (JJ:[571..579] proximal)
              (NN:[580..588] promoter))
    (VP (VBD:[589..592] was)
      (VP (VBN:[593..606] characterized)
        (NP-1 (-NONE-:[606..606] *))))
    (.:[606..607] .)))

;sentence 6 Span:608..791
;The proximal rCx40 promoter  is the most conserved noncoding region within
;the Cx40-gene known thus far and  contains five potential binding sites for
;Sp-family transcription factors.
;[621..626]:gene-protein:"rCx40"
;[687..691]:gene-rna:"Cx40"
;[759..790]:gene-protein:"Sp-family transcription factors"
(SENT
  (S
    (NP-SBJ (DT:[608..611] The) (JJ:[612..620] proximal) (NN:[621..626] rCx40)
            (NN:[627..635] promoter))
    (VP
      (VP (VBZ:[637..639] is)
        (NP-PRD
          (NP
            (NP (DT:[640..643] the)
              (ADJP (RBS:[644..648] most) (VBN:[649..658] conserved))
              (JJ:[659..668] noncoding) (NN:[669..675] region))
            (PP (IN:[676..682] within)
              (NP (DT:[683..686] the) (NN:[687..691] Cx40) (HYPH:[691..692] -)
                  (NN:[692..696] gene))))
          (VP (VBN:[697..702] known)
            (ADVP (RB:[703..707] thus) (RB:[708..711] far)))))
      (CC:[712..715] and)
      (VP (VBZ:[717..725] contains)
        (NP
          (NP (CD:[726..730] five) (JJ:[731..740] potential)
              (NN:[741..748] binding) (NNS:[749..754] sites))
          (PP (IN:[755..758] for)
            (NP (NN:[759..761] Sp) (HYPH:[761..762] -) (NN:[762..768] family)
                (NN:[769..782] transcription) (NNS:[783..790] factors))))))
    (.:[790..791] .)))

;sentence 7 Span:792..881
;The  binding of both Sp1 and Sp3 to each of these DNA elements was
;demonstrated by  EMSA.
;[813..816]:gene-protein:"Sp1"
;[821..824]:gene-protein:"Sp3"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[792..795] The) (NN:[797..804] binding))
      (PP (IN:[805..807] of)
        (NP (CC:[808..812] both) (NN:[813..816] Sp1) (CC:[817..820] and)
            (NN:[821..824] Sp3)))
      (PP (TO:[825..827] to)
        (NP
          (NP (DT:[828..832] each))
          (PP (IN:[833..835] of)
            (NP (DT:[836..841] these) (NN:[842..845] DNA)
                (NNS:[846..854] elements))))))
    (VP (VBD:[855..858] was)
      (VP (VBN:[859..871] demonstrated)
        (NP-1 (-NONE-:[871..871] *))
        (PP-MNR (IN:[872..874] by)
          (NP (NN:[876..880] EMSA)))))
    (.:[880..881] .)))

;sentence 8 Span:882..1213
;Luciferase assays of the natural rCx40 proximal promoter or mutated 
;derivatives in Cx40-expressing (NCM, primary rat neonatal cardiomyocytes and 
;A7r5, rat smooth muscle embryonic thoracic aorta cells) and -nonexpressing
;cells  (N2A, mouse neuroblastoma cells) revealed that all sites are
;contributing to  basal promoter activity.
;[882..892]:gene-protein:"Luciferase"
;[915..920]:gene-protein:"rCx40"
;[966..970]:gene-generic:"Cx40"
;[1123..1142]:malignancy-type:"neuroblastoma cells"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[882..892] Luciferase) (NNS:[893..899] assays))
      (PP (IN:[900..902] of)
        (NP
          (NP
            (NP (DT:[903..906] the) (JJ:[907..914] natural)
                (NN:[915..920] rCx40) (JJ:[921..929] proximal)
                (NN:[930..938] promoter))
            (CC:[939..941] or)
            (NP (VBN:[942..949] mutated) (NNS:[951..962] derivatives)))
          (PP-LOC (IN:[963..965] in)
            (NP
              (NP
                (ADJP
                  (NML-1 (NN:[966..970] Cx40))
                  (HYPH:[970..971] -) (VBG:[971..981] expressing))
                (PRN (-LRB-:[982..983] -LRB-)
                  (NP
                    (NP
                      (NP (NN:[983..986] NCM))
                      (,:[986..987] ,)
                      (NP (JJ:[988..995] primary) (NN:[996..999] rat)
                          (JJ:[1000..1008] neonatal)
                          (NNS:[1009..1023] cardiomyocytes)))
                    (CC:[1024..1027] and)
                    (NP
                      (NP (NN:[1029..1033] A7r5))
                      (,:[1033..1034] ,)
                      (NP (NN:[1035..1038] rat)
                        (NML (JJ:[1039..1045] smooth) (NN:[1046..1052] muscle))
                        (JJ:[1053..1062] embryonic) (JJ:[1063..1071] thoracic)
                         (NN:[1072..1077] aorta) (NNS:[1078..1083] cells)))))
                (-RRB-:[1083..1084] -RRB-)
                (NML-2 (-NONE-:[1084..1084] *P*)))
              (CC:[1085..1088] and)
              (NP
                (ADJP
                  (NML-1 (-NONE-:[1088..1088] *P*))
                  (HYPH:[1089..1090] -) (JJ:[1090..1103] nonexpressing))
                (NML-2 (NNS:[1104..1109] cells))
                (PRN (-LRB-:[1111..1112] -LRB-)
                  (NP
                    (NP (NN:[1112..1115] N2A))
                    (,:[1115..1116] ,)
                    (NP (NN:[1117..1122] mouse)
                       (NN:[1123..1136] neuroblastoma) (NNS:[1137..1142] cells)))
                  (-RRB-:[1142..1143] -RRB-))))))))
    (VP (VBD:[1144..1152] revealed)
      (SBAR (IN:[1153..1157] that)
        (S
          (NP-SBJ (DT:[1158..1161] all) (NNS:[1162..1167] sites))
          (VP (VBP:[1168..1171] are)
            (VP (VBG:[1172..1184] contributing)
              (PP (TO:[1185..1187] to)
                (NP (JJ:[1189..1194] basal) (NN:[1195..1203] promoter)
                    (NN:[1204..1212] activity))))))))
    (.:[1212..1213] .)))

;sentence 9 Span:1214..1384
;Trans-activation assays in Drosophila Schneider line 2  cells demonstrated
;that Sp1 and Sp3 activate the rCx40 proximal promoter in a  dose-dependent
;and additive manner.
;[1294..1297]:gene-protein:"Sp1"
;[1302..1305]:gene-protein:"Sp3"
;[1319..1324]:gene-protein:"rCx40"
(SENT
  (S
    (NP-SBJ
      (NP
        (NML (AFX:[1214..1219] Trans) (HYPH:[1219..1220] -)
             (NN:[1220..1230] activation))
        (NNS:[1231..1237] assays))
      (PP-LOC (IN:[1238..1240] in)
        (NP (NNP:[1241..1251] Drosophila) (NNP:[1252..1261] Schneider)
          (NML (NN:[1262..1266] line) (CD:[1267..1268] 2))
          (NNS:[1270..1275] cells))))
    (VP (VBD:[1276..1288] demonstrated)
      (SBAR (IN:[1289..1293] that)
        (S
          (NP-SBJ (NN:[1294..1297] Sp1) (CC:[1298..1301] and)
                  (NN:[1302..1305] Sp3))
          (VP (VBP:[1306..1314] activate)
            (NP (DT:[1315..1318] the) (NN:[1319..1324] rCx40)
                (JJ:[1325..1333] proximal) (NN:[1334..1342] promoter))
            (PP (IN:[1343..1345] in)
              (NP (DT:[1346..1347] a)
                (ADJP
                  (ADJP (NN:[1349..1353] dose) (HYPH:[1353..1354] -)
                        (JJ:[1354..1363] dependent))
                  (CC:[1364..1367] and)
                  (ADJP (JJ:[1368..1376] additive)))
                (NN:[1377..1383] manner)))))))
    (.:[1383..1384] .)))

;section 10 Span:1385..1416
;(C)2002 Elsevier Science (USA).
(SEC
  (FRAG (-LRB-:[1385..1386] -LRB-) (NN:[1386..1392] C-RRB-2002)
        (NNP:[1393..1401] Elsevier) (NNP:[1402..1409] Science)
        (-LRB-:[1410..1411] -LRB-) (NNP:[1411..1414] USA)
        (-RRB-:[1414..1415] -RRB-) (.:[1415..1416] .)))

;section 11 Span:1420..1465
;PMID: 11890673 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1420..1424] PMID) (::[1424..1425] :) (CD:[1426..1434] 11890673)
        (NN:[1435..1436] -LSB-) (NNP:[1436..1442] PubMed) (::[1443..1444] -)
        (NN:[1445..1452] indexed) (IN:[1453..1456] for)
        (NNP:[1457..1465] MEDLINE-RSB-)))
